Investigator
Liron Danay Sinvani
FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH · funded by NIA
- Companies
- 3
- Grants
- 3
- Non-dilutive funding
- $2.2M
- First award
- Aug 15, 2023
Resolved onto their grants.
Federal awards on file.
Summed across those awards.
Latest Jun 15, 2025.
Companies from this work
Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.
- FEINSTEIN INSTITUTE FOR MEDICAL RESEARCHMomentum in another area
NeuroGrant-only
- FEINSTEIN INSTITUTE FOR MEDICAL RESEARCHMomentum in another area
NeuroGrant-only
- FEINSTEIN INSTITUTE FOR MEDICAL RESEARCHMomentum in another area
NeuroGrant-only
Grant record
Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.
- R01
A Prospective Observational Cohort Study to Evaluate and Predict Oropharyngeal Dysphagia (OD) Improvement in Hospitalized Patients with Alzheimer's disease and related Dementias (AD/ADRD)
$852kJun 15, 2025NIAFEINSTEIN INSTITUTE FOR MEDICAL RESEARCHNIH RePORTER · 11054066 (opens the source filing in a new tab)
- R01
A Prospective Observational Cohort Study to Evaluate and Predict Oropharyngeal Dysphagia (OD) Improvement in Hospitalized Patients with Alzheimer's disease and related Dementias (AD/ADRD)
$821kJun 15, 2025NIAFEINSTEIN INSTITUTE FOR MEDICAL RESEARCHNIH RePORTER · 11345623 (opens the source filing in a new tab)
- R33
Reducing Burden in Care Partners of Community-Dwelling Persons with Dementia and Oropharyngeal Dysphagia
$537kAug 15, 2023NIAFEINSTEIN INSTITUTE FOR MEDICAL RESEARCHNIH RePORTER · 11388276 (opens the source filing in a new tab)
This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources